NORTH CHICAGO, Ill.,
Dec. 1, 2020 /PRNewswire/
-- AbbVie (NYSE: ABBV) will host a virtual immunology
strategic update for investors on Monday,
December 14, 2020 at 9:00 a.m.
Central time. Richard A.
Gonzalez, chairman of the board and chief executive officer,
and members of the executive leadership team will present on
AbbVie's immunology business and pipeline.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the webcast will be
available later that day.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram,
YouTube and LinkedIn.
View original
content:http://www.prnewswire.com/news-releases/abbvie-to-host-virtual-immunology-strategic-update-301181943.html
SOURCE AbbVie